好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Neural Repair

Friday 04/18/08
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Neuroscience Conference
Neill R. Graff-Radford, MD, FAAN
Neural Repair/Rehabilitation, Behavioral Neurology, Neurogenetics and Gene Therapy, Neurotoxicology, Aging and Dementia
Participants should be informed about current and future therapies related to neural repair.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:20 AM Welcome and Introduction
Michael Weinrich, MD
09:00 AM - 05:00 PM Abstract 001 - Theta Burst Stimulation (TBS) in Motor Rehabilitation after Stroke: Preliminary Results on a Two-Week Treatment Protocol for the Upper Limb
09:00 AM - 05:00 PM Abstract 001 - Subthalamic Nucleus Stimulation Affects Orbitofrontal Cortex in Facial Emotion Recognition: A PET Study
09:00 AM - 05:00 PM Abstract 002 - Electrical Stimulation of Spared Corticospinal Axons Strengthens Connections with and Induces Outgrowth to Spinal Motor Circuits after Injury
09:00 AM - 05:00 PM Abstract 002 - Response of Gait Dyscoordination to FES Gait Training after Stroke
09:00 AM - 05:00 PM Abstract 003 - A Quantitative Method To Assess Numbers of Axons Regenerating through a Tissue-Engineered Scaffold into Distal Spinal Cord after Transection Injury in Rats
09:00 AM - 05:00 PM Abstract 003 - Development of an RNAi Strategy for AD
09:00 AM - 05:00 PM Abstract 004 - Monitoring Post-Stroke Plasticity in Patients with Good Functional Recovery: A Comparison between Diffusion Tensor and Qball Magnetic Resonance Imaging
09:00 AM - 05:00 PM Abstract 004 - Stability of the Blind Spot as a Measure of Fixation Stability in Visual Restoration Therapy
09:00 AM - 05:00 PM Abstract 005 - Effect of Diflunisal on Neurologic Disease in Familial Transthyretin Amyloidosis
09:00 AM - 05:00 PM Abstract 006 - Murine Embryonic (mES) Derived Neural Stem Cells Transplantation Ameliorates Disease Phenotype of a Spinal Muscular Atrophy Model
09:00 AM - 05:00 PM Abstract 007 - Aberrant Channel Subunit Trafficking in the Neurodegenerative KCNC3/R420H SCA13 Phenotype
09:00 AM - 05:00 PM Abstract 008 - Peroxiredoxin 6 [ndash] A Novel Antioxidant Neuroprotective Agent
09:00 AM - 05:00 PM Abstract 009 - Human and Rat Neural Precursor Cells Cross Brain Endothelial Cells: The Implication of CD44
09:20 AM - 09:45 PM Cellular Therapies in Motor Neuron and White Matter Spinal Cord
Douglas A. Kerr, MD, PhD
09:55 AM - 10:30 PM Rewiring the Injured CNS: Lessons from the Optic Nerve
Larry Benowitz
10:30 AM - 11:00 AM Abstract presentations
11:00 AM - 11:20 AM Break and Posters
11:20 AM - 11:55 PM Noninvasive Brain Stimulation in Neurology: Perspectives on the
Alvaro Pascual-Leone, MD, PhD, FAAN
11:55 AM - 12:30 PM Synaptic Plasticity
Gary Lynch, MD
12:30 PM - 01:30 PM Luncheon
01:30 PM - 02:05 PM Treatment of Spinal Cord Injury
Mark H. Tuszynski, MD, PhD, FAAN
02:05 PM - 02:40 PM Restorative Therapies for Stroke
Steven C. Cramer, MD, FAAN
02:40 PM - 03:10 PM Abstract presentation
03:10 PM - 03:30 PM Break and Posters
03:30 PM - 04:05 PM Brain Neuroprosthesis Interface
Hunter Peckham, PhD
04:05 PM - 04:40 PM Aphasia Treatment and the Human Mirror System
Steven L. Small, MD, PhD, FAAN
04:40 PM - 05:00 PM Panel discussion
Faculty Disclosures
Nereo Bresolin, DR No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Walter J. Koroshetz, MD, FAAN Dr. Koroshetz has nothing to disclose.
Stefan M. Pulst, MD, FAAN Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Raymond P. Roos, MD, FAAN Dr. Roos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Roos has stock in Amazon. Dr. Roos has stock in Amgen. Dr. Roos has stock in Apple. Dr. Roos has stock in Cigna. Dr. Roos has stock in IBM. Dr. Roos has stock in Ionis. Dr. Roos has stock in Pfizer. Dr. Roos has received research support from Lohengrin Foundation.
Robert L. Ruff, MD, PhD, FAAN No disclosure on file
Mark H. Tuszynski, MD, PhD, FAAN No disclosure on file
Michael Weinrich, MD No disclosure on file
Anthony J. Windebank, MD, FAAN Dr. Windebank has nothing to disclose.
Alvaro Pascual-Leone, MD, PhD, FAAN Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magstim. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Pascual-Leone has stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Steven L. Small, MD, PhD, FAAN No disclosure on file
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Janice F. Wiesman, MD, FAAN No disclosure on file
Henry L. Paulson, MD, PhD, FAAN Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Duong Huynh, PhD No disclosure on file
Daniel H. Geschwind, MD, PhD Dr. Geschwind has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ovid Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Falcon Computing. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier-Biological Psychiatry. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NYAS. Dr. Geschwind has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington& Burling LLP. Dr. Geschwind has stock in none related to talk. The institution of Dr. Geschwind has received research support from CurePSP. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from Rainwater Charitable Foundation. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from The Simons Foundation. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS/NIA. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NIH/NINDS. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from U of Virginia and NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from NIH/NHGRI. The institution of Dr. Geschwind has received research support from NIH/NIMH. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care.
Steven C. Cramer, MD, FAAN Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Constant Therapeutics, BrainQ, Myomo, MicroTransponder, Panaxium, Beren Therapeutics, Medtronic, Stream Biomedical, NeuroTrauma Sciences, and TRCare. . Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.
Jose G. Romano, MD, FAAN Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Alice Fredrickson, MD No disclosure on file
Aneesh B. Singhal, MD, FAAN An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Douglas A. Kerr, MD, PhD Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation for serving as an employee of Generation Bio. Dr. Kerr has received personal compensation for serving as an employee of Atlas Venture. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has stock in Dyne Therapeutics. Dr. Kerr has stock in Generation Bio.
Janis Daly, MS PhD No disclosure on file
Sanjay P. Singh, MD, FAAN Dr. Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LIFE. Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NEURELIS.
Stefania Corti, MD, PhD Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Hunter Peckham, PhD No disclosure on file
Marc Verin Mr. Verin has nothing to disclose.
Giovanni Coppola, MD Dr. Coppola has received personal compensation for serving as an employee of Regeneron. Dr. Coppola has received stock or an ownership interest from Regeneron.
Paul Sauleau, MD No disclosure on file
John Martin No disclosure on file
Hock Luen Teoh No disclosure on file
No disclosure on file
Cristina Granziera, MD, PhD Dr. Granziera has nothing to disclose.
Godard De Ruiter, MD No disclosure on file
Jason Carmel, MD No disclosure on file
A. Gregory Sorensen, MD No disclosure on file
Larry Benowitz No disclosure on file
Beverly Davidson, PhD No disclosure on file
Ole Suhr The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation.
Pierre-Olivier Couraud No disclosure on file
Gary Lynch, MD No disclosure on file
John L. Berk John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Florence Le Jeune No disclosure on file
Edgardo Rodriguez-Lebron No disclosure on file
Nicolas Weiss No disclosure on file
Taro Yamashita, MD, PhD Dr. Yamashita has nothing to disclose.
Penelope Talelli No disclosure on file
Anthony Noto, MD Dr. Noto has nothing to disclose.
Justin Chandler, MD No disclosure on file
Nancy T. Kung No disclosure on file
Dushyant R. Damania, MBBS No disclosure on file
Bernard P. Chan, MD The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Alfonso Alejandra No disclosure on file
Benjamin Yong Qiang Tan Benjamin Yong Qiang Tan has nothing to disclose.
Robert Spinner No disclosure on file
Andrew Knight Andrew Knight has nothing to disclose.
Vijay Sharma No disclosure on file